{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:02:55Z","timestamp":1773824575532,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korean Cell Line Research Foundation"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021M3H9A1030151, 2022M3A9B6018217, NRF2022R1A5A102641311, NRF 2017R1D1A1B03036191"],"award-info":[{"award-number":["2021M3H9A1030151, 2022M3A9B6018217, NRF2022R1A5A102641311, NRF 2017R1D1A1B03036191"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021M3H9A1030151, 2022M3A9B6018217, NRF2022R1A5A102641311, NRF 2017R1D1A1B03036191"],"award-info":[{"award-number":["2021M3H9A1030151, 2022M3A9B6018217, NRF2022R1A5A102641311, NRF 2017R1D1A1B03036191"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SNUH Research Fund","award":["0320180310"],"award-info":[{"award-number":["0320180310"]}]},{"name":"SNUH Research Fund","award":["0320180310"],"award-info":[{"award-number":["0320180310"]}]},{"name":"SNUH Research Fund","award":["0320180310"],"award-info":[{"award-number":["0320180310"]}]},{"name":"SNUH Research Fund","award":["0320180310"],"award-info":[{"award-number":["0320180310"]}]},{"name":"SNUH Research Fund","award":["0320180310"],"award-info":[{"award-number":["0320180310"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27866-1","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:17:16Z","timestamp":1766146636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pressurized intraperitoneal aerosol chemotherapy enhances cisplatin efficacy in colorectal cancer organoids"],"prefix":"10.1038","volume":"15","author":[{"given":"Soon-Chan","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin Ae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Kyoung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Yong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja-Lok","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"27866_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13244-023-01417-6","volume":"14","author":"J Miguez Gonz\u00e1lez","year":"2023","unstructured":"Miguez Gonz\u00e1lez, J. et al. Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation. Insights Imaging. 14, 115. https:\/\/doi.org\/10.1186\/s13244-023-01417-6 (2023).","journal-title":"Insights Imaging"},{"key":"27866_CR2","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/s1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko, J. et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol. 17, 1709\u20131719. https:\/\/doi.org\/10.1016\/s1470-2045(16)30500-9 (2016).","journal-title":"Lancet Oncol."},{"key":"27866_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/17425247.2020.1736551","volume":"17","author":"W Ceelen","year":"2020","unstructured":"Ceelen, W., Braet, H., van Ramshorst, G., Willaert, W. & Remaut, K. Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion. Expert Opin. Drug Deliv. 17, 511\u2013522. https:\/\/doi.org\/10.1080\/17425247.2020.1736551 (2020).","journal-title":"Expert Opin. Drug Deliv"},{"key":"27866_CR4","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","volume":"20","author":"W Solass","year":"2013","unstructured":"Solass, W., Giger-Pabst, U., Zieren, J. & Reymond, M. A. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann. Surg. Oncol. 20, 3504\u20133511. https:\/\/doi.org\/10.1245\/s10434-013-3039-x (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"27866_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","volume":"47","author":"M Alyami","year":"2021","unstructured":"Alyami, M. et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur. J. Surg. Oncol. 47, 123\u2013127. https:\/\/doi.org\/10.1016\/j.ejso.2020.05.021 (2021).","journal-title":"Eur. J. Surg. Oncol."},{"key":"27866_CR6","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1245\/s10434-023-14648-0","volume":"31","author":"G Vizzielli","year":"2024","unstructured":"Vizzielli, G. et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) applied to Platinum-Resistant recurrence of ovarian tumor: A Single-Institution experience (ID: PARROT Trial). Ann. Surg. Oncol. 31, 1207\u20131216. https:\/\/doi.org\/10.1245\/s10434-023-14648-0 (2024).","journal-title":"Ann. Surg. Oncol."},{"key":"27866_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1515\/pp-2022-0116","volume":"7","author":"M Raoof","year":"2022","unstructured":"Raoof, M. et al. Multicenter dose-escalation phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design. Pleura Peritoneum. 7, 169\u2013177. https:\/\/doi.org\/10.1515\/pp-2022-0116 (2022).","journal-title":"Pleura Peritoneum"},{"key":"27866_CR8","doi-asserted-by":"publisher","unstructured":"Kurtz, F. et al. Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study. Gastroenterol Res Pract 2743985 (2018). (2018). https:\/\/doi.org\/10.1155\/2018\/2743985","DOI":"10.1155\/2018\/2743985"},{"key":"27866_CR9","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1007\/s00464-021-08567-y","volume":"35","author":"C Bachmann","year":"2021","unstructured":"Bachmann, C. et al. Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC). Surg. Endosc. 35, 6358\u20136365. https:\/\/doi.org\/10.1007\/s00464-021-08567-y (2021).","journal-title":"Surg. Endosc"},{"key":"27866_CR10","doi-asserted-by":"publisher","unstructured":"K\u00fc\u00e7\u00fckk\u00f6se, E. et al. Modeling resistance of colorectal peritoneal metastases to immune checkpoint Blockade in humanized mice. J. Immunother Cancer. 10 https:\/\/doi.org\/10.1136\/jitc-2022-005345 (2022).","DOI":"10.1136\/jitc-2022-005345"},{"key":"27866_CR11","doi-asserted-by":"publisher","first-page":"e2103360","DOI":"10.1002\/advs.202103360","volume":"9","author":"SC Kim","year":"2022","unstructured":"Kim, S. C. et al. Multifocal organoid capturing of colon cancer reveals pervasive intratumoral heterogenous drug responses. Adv. Sci. (Weinh). 9, e2103360. https:\/\/doi.org\/10.1002\/advs.202103360 (2022).","journal-title":"Adv. Sci. (Weinh)"},{"key":"27866_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41408-018-0159-3","volume":"8","author":"N Szuber","year":"2018","unstructured":"Szuber, N. et al. MPL-mutated essential thrombocythemia: a morphologic reappraisal. Blood Cancer J. 8, 121. https:\/\/doi.org\/10.1038\/s41408-018-0159-3 (2018).","journal-title":"Blood Cancer J."},{"key":"27866_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12185-021-03180-0","volume":"114","author":"S Yasuda","year":"2021","unstructured":"Yasuda, S. et al. MPL overexpression induces a high level of mutant-CALR\/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations. Int. J. Hematol. 114, 424\u2013440. https:\/\/doi.org\/10.1007\/s12185-021-03180-0 (2021).","journal-title":"Int. J. Hematol."},{"key":"27866_CR14","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00384-020-03702-y","volume":"35","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Oxaliplatin versus mitomycin C in HIPEC for peritoneal metastasis from colorectal cancer: a systematic review and meta-analysis of comparative studies. Int. J. Colorectal Dis. 35, 1831\u20131839. https:\/\/doi.org\/10.1007\/s00384-020-03702-y (2020).","journal-title":"Int. J. Colorectal Dis."},{"key":"27866_CR15","doi-asserted-by":"publisher","first-page":"14708","DOI":"10.1039\/c9ra02660f","volume":"9","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. In vitro and in vivo evaluation of a novel mitomycin nanomicelle delivery system. RSC Adv. 9, 14708\u201314717. https:\/\/doi.org\/10.1039\/c9ra02660f (2019).","journal-title":"RSC Adv."},{"key":"27866_CR16","doi-asserted-by":"publisher","first-page":"E111","DOI":"10.1503\/cjs.001619","volume":"64","author":"E Benzaquen","year":"2021","unstructured":"Benzaquen, E. et al. Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative study. Can. J. Surg. 64, E111\u2013e118. https:\/\/doi.org\/10.1503\/cjs.001619 (2021).","journal-title":"Can. J. Surg."},{"key":"27866_CR17","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1158\/1078-0432.Ccr-07-4903","volume":"14","author":"TS Bekaii-Saab","year":"2008","unstructured":"Bekaii-Saab, T. S. et al. A phase I and Pharmacokinetic study of weekly oxaliplatin followed by Paclitaxel in patients with solid tumors. Clin. Cancer Res. 14, 3434\u20133440. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-4903 (2008).","journal-title":"Clin. Cancer Res."},{"key":"27866_CR18","doi-asserted-by":"publisher","first-page":"106939","DOI":"10.1016\/j.ejps.2024.106939","volume":"203","author":"EA Elmorsy","year":"2024","unstructured":"Elmorsy, E. A. et al. Advances in Understanding cisplatin-induced toxicity: molecular mechanisms and protective strategies. Eur. J. Pharm. Sci. 203, 106939. https:\/\/doi.org\/10.1016\/j.ejps.2024.106939 (2024).","journal-title":"Eur. J. Pharm. Sci."},{"key":"27866_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4081\/oncol.2014.256","volume":"8","author":"RK Mehmood","year":"2014","unstructured":"Mehmood, R. K. Review of cisplatin and oxaliplatin in current Immunogenic and monoclonal antibody treatments. Oncol. Rev. 8, 256. https:\/\/doi.org\/10.4081\/oncol.2014.256 (2014).","journal-title":"Oncol. Rev."},{"key":"27866_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1158\/1535-7163.Mct-13-0791","volume":"13","author":"E Mukhtar","year":"2014","unstructured":"Mukhtar, E., Adhami, V. M. & Mukhtar, H. Targeting microtubules by natural agents for cancer therapy. Mol. Cancer Ther. 13, 275\u2013284. https:\/\/doi.org\/10.1158\/1535-7163.Mct-13-0791 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"27866_CR21","doi-asserted-by":"publisher","unstructured":"Daniel, S. K., Sun, B. J. & Lee, B. PIPAC for Gastrointestinal malignancies. J. Clin. Med. 12 https:\/\/doi.org\/10.3390\/jcm12216799 (2023).","DOI":"10.3390\/jcm12216799"},{"key":"27866_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/s1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net, F. et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 22, 256\u2013266. https:\/\/doi.org\/10.1016\/s1470-2045(20)30599-4 (2021).","journal-title":"Lancet Oncol."},{"key":"27866_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13193-022-01641-4","volume":"14","author":"S Mehta","year":"2022","unstructured":"Mehta, S. et al. Feasibility and safety of Taxane-PIPAC in patients with peritoneal Malignancies-a retrospective Bi-institutional study. Indian J. Surg. Oncol. 14, 1\u20139. https:\/\/doi.org\/10.1007\/s13193-022-01641-4 (2022).","journal-title":"Indian J. Surg. Oncol."},{"key":"27866_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41420-025-02593-8","volume":"11","author":"F Nie","year":"2025","unstructured":"Nie, F., Sun, X., Sun, J., Zhang, J. & Wang, Y. Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies. Cell. Death Discov. 11, 336. https:\/\/doi.org\/10.1038\/s41420-025-02593-8 (2025).","journal-title":"Cell. Death Discov"},{"key":"27866_CR25","doi-asserted-by":"publisher","unstructured":"Chaudhary, P. K. & Kim, S. An insight into GPCR and G-Proteins as cancer drivers. Cells 10 https:\/\/doi.org\/10.3390\/cells10123288 (2021).","DOI":"10.3390\/cells10123288"},{"key":"27866_CR26","doi-asserted-by":"publisher","first-page":"175883591984640","DOI":"10.1177\/1758835919846402","volume":"11","author":"F Struller","year":"2019","unstructured":"Struller, F. et al. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study. Ther. Adv. Med. Oncol. 11, 1758835919846402. https:\/\/doi.org\/10.1177\/1758835919846402 (2019).","journal-title":"Ther. Adv. Med. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27866-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:17:16Z","timestamp":1766146636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27866-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27866"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27866-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44165"}}